Strid, 2004 - Google Patents
Immunoregulation after intestinal and cutaneous exposure to food proteins: Tolerance versus sensitisationStrid, 2004
View PDF- Document ID
- 5605244000753495675
- Author
- Strid K
- Publication year
- Publication venue
- PQDT-Global
External Links
Snippet
The prevalence and severity of allergic diseases is rising and poses an increasing clinical problem. Food allergies are a major course of life-threatening hypersensitivity reactions, but the immunological mechanisms underlying the induction of sensitisation or tolerance to food …
- 206010070834 Sensitisation 0 title abstract description 47
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Similar Documents
Publication | Publication Date | Title |
---|---|---|
van Wijk et al. | Initiating mechanisms of food allergy: Oral tolerance versus allergic sensitization | |
Umetsu et al. | Regulatory T cells control the development of allergic disease and asthma | |
Roncarolo et al. | The role of different subsets of T regulatory cells in controlling autoimmunity | |
Umetsu et al. | The regulation of allergy and asthma | |
Jump et al. | Mechanisms of natural tolerance in the intestine: implications for inflammatory bowel disease | |
Groux | An overview of regulatory T cells | |
Simecka | Mucosal immunity of the gastrointestinal tract and oral tolerance | |
Hanninen et al. | γδ T cells as mediators of mucosal tolerance: the autoimmune diabetes model. | |
Mukherjee et al. | CD4+ CD25+ regulatory T cells generated in response to insulin B: 9–23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells | |
You et al. | Transforming growth factor‐β and T‐cell‐mediated immunoregulation in the control of autoimmune diabetes | |
Fujihashi et al. | Mucosal immunity and tolerance in the elderly | |
US7527972B2 (en) | Uses of bispecific antibody coated dendritic cells pulsed with antigens and GM-CSF in immune regulation | |
Rabinovitch | Immunoregulation by cytokines in autoimmune diabetes | |
Macaubas et al. | Respiratory tolerance in the protection against asthma | |
Friedman | Induction of anergy in Th1 lymphocytes by oral tolerance. Importance of antigen dosage and frequency of feeding | |
La Cava | Natural Tregs and autoimmunity | |
WO2002067863A2 (en) | Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions | |
US20040076604A1 (en) | Tolergenic antigen presenting cells and in treating immune-inflammatory conditions | |
Strid | Immunoregulation after intestinal and cutaneous exposure to food proteins: Tolerance versus sensitisation | |
Szczepanik | Skin-induced tolerance and its reversal by Toll-like receptor ligands | |
Clemente-Casares | pMHC-class II nanovaccine to treat autoimmune diseases | |
Hooper et al. | Spontaneous proliferation of Peyer's patch cells in vitro | |
Simioni et al. | Effect of aging and oral tolerance on dendritic cell function | |
Fulton et al. | of the Gastrointestinal Tract | |
Pabst et al. | Mechanisms of oral tolerance to soluble protein antigens |